| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li G et al. | Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. | 2015 | Int J Clin Exp Pathol | pmid:26884838 |
| Mizuno M et al. | Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. | 2015 | Sci Rep | pmid:26561427 |
| Morisawa T et al. | Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. | 2015 | Int Heart J | pmid:26549398 |
| Kao SY and Stankovic KM | Transactivation of human osteoprotegerin promoter by GATA-3. | 2015 | Sci Rep | pmid:26216189 |
| Kassem A et al. | TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. | 2015 | FASEB J. | pmid:26207027 |
| Ardeshirpour L et al. | OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. | 2015 | Endocrinology | pmid:25961842 |
| Reveille JD | Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. | 2015 | Clin. Rheumatol. | pmid:25939520 |
| Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
| Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |
| Hung JY et al. | Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. | 2015 | Int. J. Oncol. | pmid:25738754 |